D. Niedzwiecki

M. Ychou, C. V. D. van de Velde, P. Kienle, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data.

M. Ychou, C. V. D. van de Velde, P. Kienle, 2013, European journal of cancer.

Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells.

Donna Niedzwiecki, Eli Gilboa, Donna Yancey, 2003, Cancer research.

Insulin-Like Growth Factor-1 Is a Radial Cell-Associated Neurotrophin that Promotes Neuronal Recruitment from the Adult Songbird Ependyma/Subependyma

S. Goldman, D. Niedzwiecki, J. Mcmurtry, 1998 .

Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS.

M. Rosenblum, D. Niedzwiecki, D. Armstrong, 1990, AIDS.

Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.

J. Meyerhardt, H. Nelson, C. Fuchs, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study of pazopanib plus TH-302 in advanced solid tumors

H. Hurwitz, R. Riedel, D. Niedzwiecki, 2017, Cancer Chemotherapy and Pharmacology.

Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysis.

J. Meyerhardt, C. Fuchs, R. Goldberg, 2022, Journal of geriatric oncology.

Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance)

W. Willett, J. Meyerhardt, A. Benson, 2018, JNCI cancer spectrum.

Advancing Precision Oncology Through Biomarker-Driven Trials: Theory vs. Practice

D. Niedzwiecki, S. Halabi, 2019, CHANCE.

Safety of nifedipine in patients with hypertension: a meta-analysis.

C. Schmid, T. Chalmers, W. Stason, 1997, Hypertension.

Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma.

R. Goldberg, H. Lenz, A. Venook, 2007, Clinical colorectal cancer.

Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma.

R. Goldberg, H. Lenz, A. Venook, 2005, Clinical colorectal cancer.

Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.

J. Tepper, R. Goldberg, D. Ryan, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC 1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer

Anuradha, J. Marshall, D. Hsu, 2013 .

A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer

J. Marshall, D. Hsu, T. Crocenzi, 2013, Annals of surgery.

Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot study

H. Hurwitz, D. Niedzwiecki, Christel N. Rushing, 2015, Supportive Care in Cancer.

Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer.

N. Kemeny, D. Niedzwiecki, B. Minsky, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)

H. Hurwitz, D. Niedzwiecki, G. Blobe, 2019, Cancer Chemotherapy and Pharmacology.

Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy.

M. Bains, M. Burt, D. Niedzwiecki, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials.

M. Ychou, C. V. D. van de Velde, M. Kieser, 2019, European journal of cancer.

J. Kurtzberg, D. Niedzwiecki, G. Broadwater, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Development and Implementation of an Educational Simulation Workshop in Fiberoptic Laryngoscopy for Radiation Oncology Residents.

D. Brizel, D. Niedzwiecki, D. Yoo, 2020, International journal of radiation oncology, biology, physics.

Early 18F-FDG-PET Response During Radiotherapy for HPV-Related Oropharyngeal Cancer May Predict Disease Recurrence.

Qiuwen Wu, D. Brizel, K. Choudhury, 2020, International journal of radiation oncology, biology, physics.

Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factor.

L. Saltz, D. Niedzwiecki, K. Barbosa, 1993, Journal of the National Cancer Institute.

Comparing Outcomes of Oligometastases Treated with Hypofractionated Image-Guided Radiotherapy (HIGRT) with a Simultaneous Integrated Boost (SIB) Technique versus Metastasis Alone: A Multi-Institutional Analysis

Haijun Song, D. Niedzwiecki, J. Kirkpatrick, 2022, Cancers.

Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects

D. Niedzwiecki, G. Devi, M. Morse, 2012, Cancer Immunology, Immunotherapy.

Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2

K. Blackwell, C. Anders, P. Marcom, 2007, Journal of Translational Medicine.

Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials.

V. Diehl, J. Raemaekers, J. Radford, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: Cancer and leukemia Group B protocol 50206

B. Cheson, D. Niedzwiecki, K. Blum, 2007, Leukemia & lymphoma.

Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.

K. Sullivan, J. Kanda, D. Niedzwiecki, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Influence of regular aspirin use on survival for patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803

J. Meyerhardt, R. Schilsky, C. Fuchs, 2005 .

The impact of physical activity on patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803

J. Meyerhardt, R. Schilsky, C. Fuchs, 2005 .

Treatment Outcomes in Anaplastic Thyroid Cancer

D. Brizel, D. Niedzwiecki, Y. Mowery, 2019, Journal of thyroid research.

Validation of a 12-gene colon cancer recurrence score (RS) in patients (pts) with stage II colon cancer (CC) from CALGB 9581.

R. Schilsky, M. Bertagnolli, P. Friedman, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803)

R. Goldberg, L. Saltz, D. Hollis, 2004 .

Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803/Alliance.

J. Meyerhardt, J. Jeon, A. Benson, 2013, Clinical colorectal cancer.

Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, 5-fluorouracil and leucovorin in stage III colon cancer.

C. Compton, S. Jewell, M. Bertagnolli, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803).

R. Goldberg, L. Saltz, D. Hollis, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer.

H. Hurwitz, D. Niedzwiecki, G. Blobe, 2021, The oncologist.

Adjuvant chemotherapy for colorectal hepatic metastases: role of route of administration and timing.

D. Niedzwiecki, E. Sigurdson, D. Chapman, 1992, Surgical oncology.

Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803.

J. Meyerhardt, A. Benson, C. Fuchs, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of primary (1{o}) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance).

J. Meyerhardt, R. Schilsky, M. Bertagnolli, 2016 .

Effect of Large Prostate Volume on Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy in Patients With Prostate Cancer

D. Godfrey, D. Niedzwiecki, W. Lee, 2021, Advances in radiation oncology.

A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction che

L. Marks, D. Niedzwiecki, G. Broadwater, 2006, Bone Marrow Transplantation.

Intraportal injection of monoclonal antibody in nude mice bearing hepatic metastases

E. Voiglio, D. Niedzwiecki, Kazuhiko Yoshida, 1993, Journal of surgical oncology.

Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer

R. Lothe, J. Guinney, V. Moreno, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255

D. Niedzwiecki, B. Peterson, M. Barcos, 2000 .

Amplification of HER-2/neu gene in human gastric adenocarcinomas: correlation with primary site.

N. Altorki, D. Niedzwiecki, A. Albino, 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Initial results of CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer.

W. Frankel, D. Boffa, K. Goodman, 2017 .

A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer

N. Kemeny, D. Niedzwiecki, E. Sigurdson, 1992, Cancer.

A novel interaction of genotype, gender, and adjuvant treatment in survival after resection of stage III colon cancer: Results of CALGB 89803.

C. Compton, M. Bertagnolli, C. Atreya, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary (1°) tumor location as an independent prognostic marker from molecular features for overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB / SWOG 80405 (Alliance).

M. Bertagnolli, R. Goldberg, H. Lenz, 2017 .

Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers.

C. Compton, M. Bertagnolli, L. Wasserman, 2004, Cancer research.

Oncology clinical trials

P. Müller, T. Lai, G. Rosner, 2013 .

Image quality of EOS low-dose radiography in comparison with conventional radiography for assessment of ventriculoperitoneal shunt integrity.

D. Niedzwiecki, K. Monuszko, R. Lark, 2021, Journal of neurosurgery. Pediatrics.

Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump

N. Kemeny, D. Niedzwiecki, J. Botet, 1992, Cancer.

p27 Kip1 in Stage III Colon Cancer: Implications for Outcome Following Adjuvant Chemotherapy in CALGB 89803

M. Loda, C. Compton, S. Jewell, 2011 .

Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer.

D. Niedzwiecki, H. Lyerly, M. Morse, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Enumerating Antigen-Specific T-Cell Responses in Peripheral Blood: A Comparison of Peptide MHC Tetramer, ELISpot, and Intracellular Cytokine Analysis

D. Niedzwiecki, H. Lyerly, M. Morse, 2005, Journal of immunotherapy.

Analysis of Cellular Immune Responses in Cancer Vaccine Trials

D. Niedzwiecki, H. Lyerly, M. Morse, 2004 .

Use of Skeletal Muscle Index as a Predictor of Wait‐List Mortality in Patients With End‐Stage Liver Disease

Kara Wegermann, D. Niedzwiecki, M. Bashir, 2020, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison

E. Paulson, A. Dachman, K. Binmoeller, 2005, The Lancet.

Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance)

C. Gross, J. Meyerhardt, A. Benson, 2022, The oncologist.

The Diet of Higher Insulinemic Potential Is Not Associated with Worse Survival in Patients with Stage III Colon Cancer (Alliance)

J. Meyerhardt, A. Benson, E. Giovannucci, 2020, Cancer Epidemiology, Biomarkers & Prevention.

Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance)

J. Meyerhardt, A. Benson, E. Giovannucci, 2018, Cancer Epidemiology, Biomarkers & Prevention.

Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)

J. Meyerhardt, A. Shields, D. Niedzwiecki, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immune reconstitution in children after unrelated cord blood transplantation.

D. Niedzwiecki, P. Szabolcs, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Quality of Life Associated with Open vs Minimally Invasive Pancreaticoduodenectomy: A Prospective Pilot Study.

Emily K. E. McCracken, D. Niedzwiecki, D. Moris, 2022, Journal of the American College of Surgeons.

Prospective randomized phase II trial of pazopanib versus placebo in patients with progressive carcinoid tumors (CARC) (Alliance A021202).

L. Schwartz, J. Meyerhardt, M. Maitland, 2019, Journal of Clinical Oncology.

Randomized phase II study of everolimus (E) versus everolimus plus bevacizumab (E+B) in patients (Pts) with locally advanced or metastatic pancreatic neuroendocrine tumors (pNET), CALGB 80701 (Alliance).

N. Foster, A. Venook, H. Kennecke, 2015 .

Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease.

James T. Lin, B. Schweitzer, J. Bertino, 1993, Leukemia.

Histologic predictors of survival in acquired immunodeficiency syndrome-associated Kaposi's sarcoma.

B. Safai, D. Niedzwiecki, P. Myskowski, 1992, Human pathology.

Esophageal Function Tests are Not Associated with Barium Swallow Findings in Advanced Lung Disease

Rajan T. Gupta, D. Fisher, D. Niedzwiecki, 2020, Dysphagia.

Esophageal contractility increases and gastroesophageal reflux does not worsen after lung transplantation.

J. Reynolds, D. Fisher, D. Niedzwiecki, 2019, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Overcoming Drug Resistance in Mantle Cell Lymphoma Using a Combination of Dose-Dense and Intense Therapy

F. Ali-Osman, L. Prosnitz, D. Niedzwiecki, 2010, Cancer investigation.

Low‐dose weekly paclitaxel for recurrent or refractory aggressive non‐Hodgkin lymphoma

D. Niedzwiecki, C. Decastro, D. Rizzieri, 2004, Cancer.

High Dose Cyclophosphamide Plus Recombinant Human Granulocyte-colony Stimulating Factor (rhG-CSF) in the Treatment of Follicular, Low Grade Non-Hodgkin's Lymphoma: CALGB 9150

J. Sklar, R. Schilsky, G. Petroni, 2001, Leukemia & lymphoma.

Phase II study of oral eniluracil, 5‐fluorouracil, and leucovorin in patients with advanced colorectal carcinoma

R. Schilsky, D. Hollis, D. Niedzwiecki, 2001, Cancer.

501OCALGB/SWOG 80405: PHASE III TRIAL OF IRINOTECAN/5-FU/LEUCOVORIN (FOLFIRI) OR OXALIPLATIN/5-FU/LEUCOVORIN (MFOLFOX6) WITH BEVACIZUMAB (BV) OR CETUXIMAB (CET) FOR PATIENTS (PTS) WITH EXPANDED RAS ANALYSES UNTREATED METASTATIC ADENOCARCINOMA OF THE COLON OR RECTUM (MCRC)

R. Schilsky, M. Bertagnolli, R. Goldberg, 2014 .

Trastuzumab and tucatinib for the treatment of HER2 amplified metastatic colorectal cancer (mCRC): Initial results from the MOUNTAINEER trial

N. Kemeny, A. Cercek, T. Bekaii-Saab, 2019, Annals of Oncology.

Postoperative adjuvant chemoradiation for gastric or gastroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT: Intergroup trial CALGB 80101.

C. Willett, C. Fuchs, J. Tepper, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors

H. Hurwitz, J. Bendell, D. Niedzwiecki, 2019, Cancer Chemotherapy and Pharmacology.

Advanced pancreatic cancer: a phase I-II trial of cisplatin, high-dose cytarabine, and caffeine.

N. Kemeny, D. Niedzwiecki, J. Botet, 1989, Journal of the National Cancer Institute.

KRAS mutation, cancer recurrence, and patient survival in stage III colon cancer: Findings from CALGB 89803.

J. Meyerhardt, M. Bertagnolli, S. Ogino, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Presence of 18q loss of heterozygosity (LOH) and disease-free and overall survival in stage II colon cancer: CALGB Protocol 9581.

S. Jewell, M. Bertagnolli, R. Goldberg, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surgical resection is associated with improved long-term survival of patients with resectable pancreatic head cancer compared to multiagent chemotherapy.

D. Niedzwiecki, K. Landa, Marcelo Cerullo, 2021, HPB : the official journal of the International Hepato Pancreato Biliary Association.

O-0019CALGB/SWOG 80405: PHASE III TRIAL OF IRINOTECAN/5-FU/LEUCOVORIN (FOLFIRI) OR OXALIPLATIN/5-FU/LEUCOVORIN (MFOLFOX6) WITH BEVACIZUMAB (BV) OR CETUXIMAB (CET) FOR PATIENTS (PTS) WITH KRAS WILD-TYPE (WT) UNTREATED METASTATIC ADENOCARCINOMA OF THE COLON

R. Schilsky, M. Bertagnolli, R. Goldberg, 2014 .

Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration.

R. Labianca, J. Meyerhardt, D. Sargent, 2017 .

Somatic DNA mutations, MSI status, mutational load (ML): Association with overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC) of CALGB/SWOG 80405 (Alliance).

M. Bertagnolli, R. Goldberg, H. Lenz, 2017 .

Impact of consensus molecular subtyping (CMS) on overall survival (OS) and progression free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance).

M. Bertagnolli, R. Goldberg, H. Lenz, 2017 .

Role of folylpolyglutamates in biochemical modulation of fluoropyrimidines by leucovorin.

J. Bertino, D. Niedzwiecki, D. Priest, 1991, Cancer research.

CALGB 80403/ECOG 1206: A randomized phase II study of three standard chemotherapy regimens (ECF, IC, FOLFOX) plus cetuximab in metastatic esophageal and GE junction cancer.

A. Benson, R. Goldberg, P. Enzinger, 2010 .

Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency

R. Motzer, H. Scher, G. Bosl, 2004, Cancer Chemotherapy and Pharmacology.

LBA21_PRProspective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): Updated results of IDEA (International Duration Evaluation of Adjuvant chemotherapy)

R. Labianca, J. Meyerhardt, D. Sargent, 2017 .

Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C

C. Moylan, D. Niedzwiecki, M. Kappus, 2020, Transplantation.

Insulin-like growth factor-1 is a radial cell-associated neurotrophin that promotes neuronal recruitment from the adult songbird edpendyma/subependyma.

S. Goldman, D. Niedzwiecki, J. Mcmurtry, 1998, Journal of neurobiology.

Prolonged follow‐up after initial therapy with 2‐chlorodeoxyadenosine in patients with indolent non‐Hodgkin lymphoma

J. Byrd, B. Cheson, A. Saven, 2006, Cancer.

How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?

D. Niedzwiecki, G. Canellos, Jeffrey L. Johnson, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relative variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer.

R. Lothe, J. Guinney, V. Moreno, 2019 .

A new syndrome: ascites, hyperbilirubinemia, and hypoalbuminemia after biochemical modulation of fluorouracil with N-phosphonacetyl-L-aspartate (PALA)

N. Kemeny, R. Kurtz, D. Niedzwiecki, 1991, Annals of internal medicine.

Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901

M. Czuczman, B. Cheson, D. Niedzwiecki, 2007, Leukemia & lymphoma.

Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Fidelity of Diagnosis Using WHO Criteria.

C. McCall, D. Niedzwiecki, C. Kelsey, 2020, Clinical lymphoma, myeloma & leukemia.

Effective Pain Control With Very Low Dose Palliative Radiation Therapy for Patients With Multiple Myeloma With Uncomplicated Osseous Lesions

M. Arcasoy, D. Niedzwiecki, C. Kelsey, 2021, Advances in radiation oncology.

Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34.

D. Niedzwiecki, O. Colvin, N. Chao, 2005, Blood.

Phase I Study of Immunizationwith Dendritic Cells Modifiedwith Fowlpox Encoding Carcinoembryonic Antigen and CostimulatoryMolecules

J. Schlom, D. Niedzwiecki, H. Lyerly, 2005 .

Metastatic Adenocarcinomas of Unknown Primary Site: Prognostic Variables and Treatment Results

D. Niedzwiecki, V. Vinciguerra, D. Kelsen, 1990, American journal of clinical oncology.

Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.

R. Goldberg, L. Saltz, D. Hollis, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance)

J. Meyerhardt, A. Benson, M. Bertagnolli, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical Predictors of a Positive Ct Angiogram Study Used for the Evaluation of Acute Gastrointestinal Hemorrhage

D. Niedzwiecki, A. Parish, Zachary P. Spiritos, 2022, Digestive Diseases and Sciences.

AIDS-associated Kaposi's sarcoma: variables associated with survival.

B. Safai, D. Niedzwiecki, P. Myskowski, 1988, Journal of the American Academy of Dermatology.

Variability in endoscopic assessment of Nissen fundoplication wrap integrity and hiatus herniation.

D. Niedzwiecki, D. Leiman, Abraham Khan, 2021, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Flow cytometry as a predictive indicator in patients with operable gastric cancer.

D. Niedzwiecki, M. Brennan, D. Nanus, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictors of Clinical Outcome after Treatment of Intracranial Aneurysms with the Pipeline Embolization Device (PED).

Tony P. Smith, A. Zomorodi, D. Niedzwiecki, 2019, World neurosurgery.

J. Kurtzberg, D. Niedzwiecki, G. Broadwater, 2003 .

Clinical Utility of Near-infrared Device in Detecting Traumatic Intracranial Hemorrhage: A Pilot Study Toward Application as an Emergent Diagnostic Modality in a Low Resource Setting.

D. Niedzwiecki, R. Gramer, A. Fuller, 2022, Journal of neurotrauma.

Histology of early lesions of AIDS-associated Kaposi's sarcoma.

B. Safai, D. Niedzwiecki, P. Myskowski, 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

In vitro neurogenesis by neuronal precursor cells derived from the adult songbird brain

S. Goldman, D. Niedzwiecki, A. Zaremba, 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Induction of Wilms' Tumor Protein (WT1)–Specific Antitumor Immunity Using a Truncated WT1-Expressing Adenovirus Vaccine

D. Niedzwiecki, H. Lyerly, M. Morse, 2009, Clinical Cancer Research.

Heterogeneity of Tardive Dyskinesia

D. Niedzwiecki, W. Glazer, J. Hughes, 1988, British Journal of Psychiatry.

High-dose human lymphoblastoid interferon in metastatic colorectal cancer: clinical results and modification of biological responses.

J. Gabrilove, D. Niedzwiecki, D. Mintzer, 1987, Cancer treatment reports.

An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer.

D. Niedzwiecki, H. Lyerly, G. Devi, 2010, The Journal of clinical investigation.

Superiority of trimodality therapy to surgery alone in esophageal cancer: Results of CALGB 9781.

C. Reed, J. Tepper, K. Kiel, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Thymic epithelial defects and predisposition to autoimmune disease in BB rats.

D. Niedzwiecki, D. Greiner, J. Mordes, 1994, The American journal of pathology.

Probiotics in Inflammatory Bowel Disease: yet Another Mechanism of Action?

J. Yee, E. Paulson, M. Roddie, 2022 .

Dietary fat in relation to all‐cause mortality and cancer progression and death among people with metastatic colorectal cancer: Data from CALGB 80405 (Alliance)/SWOG 80405

J. Meyerhardt, E. Giovannucci, R. Goldberg, 2022, International journal of cancer.

Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatin.

E. Oki, F. Baehner, A. Venook, 2022, Journal of gastrointestinal oncology.

Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution.

K. Sullivan, D. Niedzwiecki, C. Decastro, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.

V. Rusch, L. Saltz, D. Niedzwiecki, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II study of bortezomib in relapsed Hodgkin lymphoma: Preliminary results of CALGB 50206.

B. Cheson, D. Niedzwiecki, K. Blum, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictors of Abnormal Functional Luminal Impedance Planimetry Findings in Non-mechanical Esophagogastric Junction Outflow Obstruction

D. Niedzwiecki, D. Leiman, A. Parish, 2020, Digestive Diseases and Sciences.

Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer.

L. Saltz, D. Niedzwiecki, M. Brennan, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance).

M. Bertagnolli, P. Wirapati, R. Goldberg, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance)

W. Willett, J. Meyerhardt, A. Benson, 2018, PloS one.

System for High-Intensity Evaluation During Radiation Therapy (SHIELD-RT): A Prospective Randomized Study of Machine Learning-Directed Clinical Evaluations During Radiation and Chemoradiation.

Julian C. Hong, J. Tenenbaum, D. Niedzwiecki, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer.

N. Kemeny, D. Niedzwiecki, D. Martin, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Orthotopic Transplantation of the Full-length Porcine Intestine After Normothermic Machine Perfusion

Katherine S. Garman, D. Niedzwiecki, D. Sudan, 2022, Transplantation direct.

A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.

J. Kurtzberg, D. Niedzwiecki, K. Komanduri, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines.

D. Niedzwiecki, H. Lyerly, M. Morse, 2008, Blood.

Vitamin D status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance).

J. Meyerhardt, C. Fuchs, H. Lenz, 2015 .

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors.

E. Gilboa, P. Dahm, D. Niedzwiecki, 2002, The Journal of clinical investigation.

Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581.

C. Compton, D. Kerr, M. Bertagnolli, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance)

J. Meyerhardt, C. Fuchs, R. Goldberg, 2019, Clinical Cancer Research.

Etoposide in prostatic cancer: experimental studies and phase II trial in patients with bidimensionally measurable disease

H. Scher, C. Sternberg, D. Niedzwiecki, 2004, Cancer Chemotherapy and Pharmacology.

Interferon-α with Zidovudine: Safety, Tolerance, and Clinical and Virologic Effects in Patients with Kaposi Sarcoma Associated with the Acquired Immunodeficiency Syndrome (AIDS)

B. Brew, D. Niedzwiecki, B. Gansbacher, 1990 .

Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)

B. Brew, D. Niedzwiecki, B. Gansbacher, 1990, Annals of internal medicine.

Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer.

N. Kemeny, D. Niedzwiecki, E. Sigurdson, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.

C. Lightdale, L. Saltz, D. Niedzwiecki, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A pilot study of hepatic artery floxuridine combined with systemic 5‐fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases

N. Kemeny, D. Niedzwiecki, E. Sigurdson, 1993, Cancer.

Characterization of sporadic colon cancer by patterns of genomic instability.

C. Compton, D. Chang, M. Bertagnolli, 2003, Cancer research.

Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers

C. Compton, C. Boland, M. Bertagnolli, 2004, International journal of cancer.

Evaluation of Microsatellite Instability, hMLH1 Expression and hMLH1 Promoter Hypermethylation in Defining the MSI Phenotype of Colorectal Cancer

C. Compton, M. Bertagnolli, L. Wasserman, 2004, Cancer biology & therapy.

Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome.

Donna Niedzwiecki, Federico Innocenti, Fang-Shu Ou, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fluoropyrimidines by Leucovorin Role of Folylpolyglutamates in Biochemical Modulation of Updated

James T. Lin, D. Niedzwiecki, D. Priest, 2006 .

The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.

C. Compton, M. Bertagnolli, R. Goldberg, 2007, Gastroenterology.

Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.

J. Meyerhardt, A. Benson, C. Fuchs, 2012, Journal of the National Cancer Institute.

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

J. Meyerhardt, R. Schilsky, M. Bertagnolli, 2017, JAMA.

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

D. Sugarbaker, C. Willett, C. Reed, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Optimizing Management of the Central Nervous System in Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Stem Cell Transplantation

D. Niedzwiecki, C. Kelsey, M. Horwitz, 2022, Advances in radiation oncology.

Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104)

G. Linette, F. Haluska, D. Niedzwiecki, 2012, Journal of Translational Medicine.

Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104)

G. Linette, F. Haluska, D. Niedzwiecki, 2006, Journal of Translational Medicine.

A phase 2 trial of gemcitabine, 5‐fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma

J. Tepper, R. Goldberg, D. Hollis, 2011, Cancer.

Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.

J. Meyerhardt, A. Benson, C. Willett, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114.

J. Tepper, M. O’connell, D. Hollis, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of number of nodes retrieved on outcome in patients with rectal cancer.

C. Compton, J. Tepper, A. Benson, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.

J. Tepper, A. Benson, M. O’connell, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hospital‐level compliance with the commission on cancer’s quality of care measures and the association with patient survival

M. Mcclellan, R. Saunders, D. Niedzwiecki, 2021, Cancer medicine.

Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma

Edward J. Lee, C. Bloomfield, R. Larson, 2004, Cancer.

Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance)

W. Willett, J. Meyerhardt, E. Giovannucci, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance)

J. Meyerhardt, A. Benson, E. Giovannucci, 2018, Cancer Epidemiology, Biomarkers & Prevention.

Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.

D. Spiegelman, J. Meyerhardt, A. Benson, 2013, Journal of the National Cancer Institute.

Pain and depression in patients with newly diagnosed pancreas cancer.

H. Thaler, K. Foley, D. Niedzwiecki, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors

L. Saltz, D. Niedzwiecki, D. Kelsen, 1993, Cancer.

Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer.

I. Tsigelny, C. Atreya, F. Meric-Bernstam, 2018, Cancer discovery.

Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial.

J. Meyerhardt, E. Giovannucci, S. Ogino, 2019, European journal of cancer.

Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581.

R. Schilsky, M. Bertagnolli, P. Friedman, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.

C. Compton, S. Jewell, M. Bertagnolli, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405

J. Meyerhardt, A. Benson, C. Fuchs, 2020, JNCI cancer spectrum.

p27Kip1 in Stage III Colon Cancer: Implications for Outcome following Adjuvant Chemotherapy in Cancer and Leukemia Group B Protocol 89803

M. Loda, C. Compton, S. Jewell, 2009, Clinical Cancer Research.

p 27 Kip 1 in Stage IIIColon Cancer : Implications for Outcome following Adjuvant Chemotherapy in Cancer and Leukemia Group BProtocol 89803

C. Compton, S. Jewell, M. Bertagnolli, 2009 .

A phase I/II study of preoperative oxaliplatin (O), 5-fluorouracil (5-FU), and external beam radiation therapy (XRT) in locally advanced rectal cancer: CALGB 89901.

J. Tepper, D. Ryan, D. Hollis, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer.

D. Sargent, R. Schilsky, M. O’connell, 2001, The New England journal of medicine.

Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: Results of CALGB 59906

Sonali M. Smith, B. Cheson, D. Niedzwiecki, 2006, Leukemia & lymphoma.

Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials.

Donna Niedzwiecki, Edward L Korn, Michael B Atkins, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene Expression Markers of Efficacy and Resistance to Cetuximab Treatment in Metastatic Colorectal Cancer: Results from CALGB 80203 (Alliance)

Ivo D. Shterev, K. Owzar, H. Hurwitz, 2014, Clinical Cancer Research.

Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer 1

Donna Niedzwiecki, Eli Gilboa, Philipp Dahm, 2005, The Journal of Immunology.

APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q1

C. Compton, M. Bertagnolli, L. Wasserman, 2004, Cancer biology & therapy.

Ependymal/subependymal zone cells of postnatal and adult songbird brain generate both neurons and nonneuronal siblings in vitro and in vivo.

S. Goldman, T. Mikawa, D. Niedzwiecki, 1996, Journal of neurobiology.

Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS.

D. Niedzwiecki, N. Flomenberg, S. Krown, 1991, Journal of acquired immune deficiency syndromes.

Phase Ib/II study of pembrolizumab with lanreotide depot for advanced, progressive gastroenteropancreatic neuroendocrine tumors (PLANET).

H. Hurwitz, D. Hsu, D. Niedzwiecki, 2021 .

Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).

R. Schilsky, R. Goldberg, H. Hurwitz, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150.

J. Sklar, R. Schilsky, G. Petroni, 2001 .

Phase I Study of Immunization with Dendritic Cells Modified with Fowlpox Encoding Carcinoembryonic Antigen and Costimulatory Molecules

J. Schlom, D. Niedzwiecki, H. Lyerly, 2005, Clinical Cancer Research.

Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients

D. Niedzwiecki, M. Morse, H. Lyerly, 2015, Journal of Immunotherapy for Cancer.

Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain

A. Houghton, F. Haluska, D. Niedzwiecki, 2006, Cancer.

Fibrin glue as an adjuvant dural sealant reduces the rate of perioperative complications in posterior fossa decompression with duraplasty: A single center experience in 165 adult Chiari I patients

M. Krucoff, D. Niedzwiecki, C. Bagley, 2019, Journal of Clinical Neuroscience.

Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.

J. Meyerhardt, A. Benson, M. Bertagnolli, 2011, Journal of the National Cancer Institute.

KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803

J. Meyerhardt, A. Benson, M. Bertagnolli, 2009, Clinical Cancer Research.

Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer.

J. Meyerhardt, C. Fuchs, R. Goldberg, 2020, JAMA oncology.

Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial.

L. Schwartz, J. Meyerhardt, M. Bertagnolli, 2019, JAMA oncology.

Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer

H. Lenz, H. Hurwitz, M. Fakih, 2022, JAMA network open.

Local Tumor Control and Patient Outcome Using Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: iRECIST as a Potential Substitute for Traditional Criteria.

D. Marin, D. Godfrey, D. Niedzwiecki, 2019, AJR. American journal of roentgenology.

An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance)

Y. Furukawa, K. Owzar, M. Ratain, 2019, Pharmacogenetics and genomics.

Immune reconstitution after unrelated cord blood transplantation.

D. Niedzwiecki, P. Szabolcs, 2007, Cytotherapy.

25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance).

K. Owzar, K. Van Loon, C. Fuchs, 2014, Journal of the National Cancer Institute.

Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation.

K. Sullivan, J. Kanda, D. Niedzwiecki, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase 2 Study of the g209-2M Melanoma Peptide Vaccine and Low-Dose Interleukin-2 in Advanced Melanoma: Cancer and Leukemia Group B 509901

John D Roberts, Donna Niedzwiecki, Alan Houghton, 2006, Journal of immunotherapy.

/II vitro Neurogenesis Adult Songbird Brain by Neuronal Precursor Derived

D. Niedzwiecki, A. Zaremba, S. Goldman, 2003 .

Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.

F. Hu, J. Meyerhardt, H. Nelson, 2007, JAMA.

Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.

J. Meyerhardt, R. Schilsky, H. Nelson, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.

J. Meyerhardt, A. Benson, C. Willett, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Alterations in DNA methylation associate with fatty liver and metabolic abnormalities in a multi-ethnic cohort of pre-teenage children

Dereje D. Jima, S. Murphy, C. Moylan, 2022, Epigenetics.

Relationship and Prognostic Value of Endogenous Interferon-α, β2-Microglobulin, and Neopterin Serum Levels in Patients with Kaposi Sarcoma and AIDS

D. Niedzwiecki, N. Flomenberg, S. Krown, 1991 .

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

R. Labianca, J. Meyerhardt, D. Sargent, 2018, The New England journal of medicine.

Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial

J. Meyerhardt, A. Benson, E. Giovannucci, 2018, JAMA oncology.

Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).

N. Kemeny, J. Herndon, H. Lenz, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance).

J. Meyerhardt, C. Willett, C. Fuchs, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.

J. Byrd, A. LaCasce, B. Cheson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904.

R. Goldberg, M. Tempero, P. Enzinger, 2009, Journal of Clinical Oncology.

Intrinsic radiomic expression patterns after 20 Gy demonstrate early metabolic response of oropharyngeal cancers.

Kyle J. Lafata, F. Yin, D. Brizel, 2021, Medical physics.

Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.

J. Meyerhardt, M. Bertagnolli, C. Fuchs, 2021, JAMA.

Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance)

K. Owzar, M. Ratain, C. Willet, 2021, Pharmacogenetics and genomics.

Long-term follow-up of Hodgkin's disease trial.

D. Niedzwiecki, G. Canellos, 2002, The New England journal of medicine.

Association of family history with cancer recurrence and survival among patients with stage III colon cancer.

J. Meyerhardt, M. Bertagnolli, C. Fuchs, 2008, JAMA.

Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio

D. Hsu, D. Niedzwiecki, H. Lyerly, 2020, Journal for ImmunoTherapy of Cancer.

Sentinel Node Staging of Resectable Colon Cancer: Results of a Multicenter Study

C. Compton, M. Bertagnolli, M. Zinner, 2004, Annals of surgery.

E. Basch, D. Schrag, J. Weeks, 2012, Journal of pain and symptom management.

Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001.

C. Compton, S. Jewell, M. Bertagnolli, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anticipatory immune suppression and nausea in women receiving cyclic chemotherapy for ovarian cancer.

J. Holland, D. Niedzwiecki, S. Rubin, 1990, Journal of consulting and clinical psychology.

Intrahepatic mitomycin C as a salvage treatment for patients with hepatic metastases from colorectal carcinoma

D. Niedzwiecki, A. Schneider, D. Chapman, 1989, Cancer.

Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement

N. Kemeny, D. Niedzwiecki, P. Oderman, 1989, Cancer.

Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease.

Y. Tanaka, D. Niedzwiecki, D. Rizzieri, 2008, Cytotherapy.

Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum.

S M Larson, S. Larson, D. Niedzwiecki, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials.

R. Labianca, J. Meyerhardt, V. Torri, 2020, The Lancet. Oncology.

The impact of neuroleptic medication on tardive dyskinesia: a meta-analysis of published studies.

P. Nourjah, D. Niedzwiecki, W. Glazer, 1987, American journal of public health.

Recumbent Total Skin Electron Beam Therapy

P. Laug, Qiuwen Wu, D. Niedzwiecki, 2021, Advances in radiation oncology.

Thalidomide has limited single‐agent activity in relapsed or refractory indolent non‐Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B

Sonali M. Smith, B. Cheson, D. Niedzwiecki, 2008, British journal of haematology.

Cabozantinib with or without Panitumumab for RAS wild-type metastatic colorectal cancer: impact of MET amplification on clinical outcomes and circulating biomarkers

D. Niedzwiecki, Yingmiao Liu, J. Strickler, 2022, Cancer Chemotherapy and Pharmacology.

Intrinsic resistance to methotrexate in human soft tissue sarcoma cell lines.

B. Schweitzer, J. Bertino, D. Niedzwiecki, 1992, Cancer research.

Racial and Socioeconomic Disparities in Utilization of Telehealth in Patients with Liver Disease During COVID-19

Kara Wegermann, D. Niedzwiecki, A. Muir, 2021, Digestive Diseases and Sciences.

Tenascin and microvessel stromal changes in patients with non-Hodgkin's lymphoma are isolated to the sites of disease and vary in correlation to disease activity

D. Bigner, D. Niedzwiecki, M. Wadleigh, 2005, Leukemia & lymphoma.

Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.

J. Meyerhardt, A. Benson, E. Giovannucci, 2015, Journal of the National Cancer Institute.

ToxÂ ¡ city , Elimination , and Metabolism of 10-Ethyl-lO-deazaaminopterin in Rats and Dogs 1

T. Chou, S. Sternberg, D. Niedzwiecki, 2006 .

Toxicity, elimination, and metabolism of 10-ethyl-10-deazaaminopterin in rats and dogs.

T. Chou, S. Sternberg, D. Niedzwiecki, 1987, Cancer research.

Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)

J. Meyerhardt, C. Fuchs, R. Goldberg, 2019, JNCI cancer spectrum.

The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial.

S. Datta, J. Wong, D. Niedzwiecki, 2018, Contemporary clinical trials.

Genetic variation determines VEGF-A plasma levels in cancer patients

Ivo D. Shterev, R. Gordân, Y. Furukawa, 2018, Scientific Reports.

Optimizing collection of adverse event data in cancer clinical trials supporting supplemental indications.

R. Schilsky, J. Abrams, D. Niedzwiecki, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers.

A. Benson, R. Goldberg, P. Enzinger, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance)

W. Willett, J. Meyerhardt, A. Benson, 2014, PloS one.

Impact of smoking on patients with stage III colon cancer

J. Meyerhardt, A. Benson, R. Goldberg, 2010, Cancer.

Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: findings from CALGB 89803 and CALGB 80405.

J. Meyerhardt, K. Van Loon, C. Fuchs, 2013, Clinical colorectal cancer.

Impact of Malnutrition on Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Insertion

D. Niedzwiecki, M. Kappus, A. Muir, 2020, Digestive Diseases and Sciences.

Safety of nifedipine in angina pectoris: a meta-analysis.

C. Schmid, T. Chalmers, W. Stason, 1999, Hypertension.

Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance)

C. Gross, J. Meyerhardt, A. Benson, 2021, JNCI cancer spectrum.

Long-term follow-up of survival in Hodgkin's lymphoma.

D. Niedzwiecki, G. Canellos, Jeffrey L. Johnson, 2009, The New England journal of medicine.

Blood‐based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)

K. Owzar, H. Hurwitz, A. Venook, 2016, Cancer medicine.

Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281).

J. Tepper, R. Goldberg, D. Niedzwiecki, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Factors Associated with 30-Day Mortality Among Patients Undergoing Brain Metastases Radiotherapy

D. Niedzwiecki, J. Kirkpatrick, D. Natesan, 2023, Advances in Radiation Oncology.

Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance).

W. Willett, F. Hu, J. Meyerhardt, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MRE11-Deficiency Associated with Improved Long-Term Disease Free Survival and Overall Survival in a Subset of Stage III Colon Cancer Patients in Randomized CALGB 89803 Trial

M. Bertagnolli, M. Emond, P. Rabinovitch, 2014, PloS one.

Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia.

B. Schweitzer, J. Bertino, D. Niedzwiecki, 1991, Leukemia research.

Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance).

R. Schilsky, M. Bertagnolli, T. Davison, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603).

R. Schilsky, R. Goldberg, G. Abou-Alfa, 2010, The oncologist.

Association between physical activity and the time course of cancer recurrence in stage III colon cancer

J. Meyerhardt, A. Shields, D. Niedzwiecki, 2023, British Journal of Sports Medicine.

Celecoxib in addition to standard adjuvant therapy with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in stage III colon cancer: Results from CALGB/SWOG 80702.

J. Meyerhardt, M. Bertagnolli, C. Fuchs, 2020 .

Multiagent Chemotherapy for Isolated Colorectal Liver Metastases: A Single-centered Retrospective Study

H. Hurwitz, J. Bendell, D. Niedzwiecki, 2008, Journal of Gastrointestinal Surgery.

The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation

Yusuke Nakamura, R. Gordân, W. Bamlet, 2018, PloS one.

A double-blind, placebo-controlled, randomized phase III trial of gemcitabine (G) plus bevacizumab (B) versus gemcitabine plus placebo (P) in patients (pts) with advanced pancreatic cancer (PC): A preliminary analysis of Cancer and Leukemia Group B (CALGB

R. Schilsky, H. McLeod, R. Goldberg, 2007 .

BACCI: A phase II randomized, double-blind, multicenter, placebo-controlled study of capecitabine (C) bevacizumab (B) plus atezolizumab (A) or placebo (P) in refractory metastatic colorectal cancer (mCRC): An ACCRU network study

A. Grothey, H. Hurwitz, M. Fakih, 2019, Annals of Oncology.

Cancer and Leukemia Group B Gastrointestinal Cancer Committee

M. Bertagnolli, J. Tepper, R. Goldberg, 2006, Clinical Cancer Research.

Randomized Phase II Study of PET Response–Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial

Kisha Mitchell, J. Meyerhardt, W. Frankel, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405

J. Meyerhardt, C. Fuchs, R. Goldberg, 2020, JNCI cancer spectrum.

Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance)

W. Willett, J. Meyerhardt, A. Benson, 2018, Journal of the National Cancer Institute.

Preliminary Analysis of Cancer and Leukemia Group B (CALGB) 80003: A Phase II Trial of Gemcitabine, 5-Fluorouracil (5FU), and Radiation Therapy (RT) in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma

C. Fuchs, J. Tepper, R. Goldberg, 2005 .

Survival in Young-Onset Metastatic Colorectal Cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80405.

J. Meyerhardt, K. Van Loon, C. Fuchs, 2021, Journal of the National Cancer Institute.

Prospective comparison of patient experience with colon imaging tests.

J. Yee, E. Bini, E. Paulson, 2006, The American journal of medicine.

Sentinel node staging of resectable colon cancer: Results of CALGB 80001.

C. Compton, M. Bertagnolli, M. Redston, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III trial of adjuvant immunotherapy with MOAb 17-1A following resection for stage II adenocarcinoma of the colon (CALGB 9581).

C. Compton, D. Kerr, A. Benson, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Plasma protein markers in advanced or metastatic colorectal cancer patients receiving chemotherapy with bevacizumab or cetuximab: Results from CALGB 80405 (Alliance).

J. Meyerhardt, K. Owzar, H. Lenz, 2021, Clinical Cancer Research.

Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance)

K. Owzar, M. Ratain, P. Friedman, 2018, Clinical Cancer Research.

Title Identification of a Genomic Region between SLC 29 A 1 and HSP 90 AB 1 Associated with Risk of Bevacizumab-Induced Hypertension : CALGB 80405 ( Alliance )

K. Owzar, M. Ratain, P. Friedman, 2018 .

Evaluating for disparities in place of death for head and neck cancer patients in the United States utilizing the CDC WONDER database.

D. Niedzwiecki, Y. Mowery, J. Chino, 2020, Oral oncology.

BACCI: A phase II randomized, double-blind, placebo-controlled study of capecitabine bevacizumab plus atezolizumab versus capecitabine bevacizumab plus placebo in patients with refractory metastatic colorectal cancer.

A. Grothey, H. Hurwitz, M. Fakih, 2018 .

A phase III comparison trial of streptozotocin, mitomycin, and 5‐fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma

Clifford Hudis, E. Casper, D. Niedzwiecki, 1991, Cancer.

Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405.

J. Meyerhardt, C. Fuchs, R. Goldberg, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase II Prospective Multi-Institutional Trial of Adjuvant Active Specific Immunotherapy Following Curative Resection of Colorectal Cancer Hepatic Metastases: Cancer and Leukemia Group B Study 89903

R. Schilsky, R. Goldberg, A. Venook, 2009, Annals of Surgical Oncology.

A Phase II Prospective Multi-institutional Trial of Adjuvant Active Specific Immunotherapy Following Curative Resection of Colorectal Cancer Hepatic Metastases: Cancer and Leukemia Group B Study 89903

R. Schilsky, R. Goldberg, A. Venook, 2007, Annals of Surgical Oncology.

Use, Yield, and Risk of Device-assisted Enteroscopy in the United States

S. Gross, D. Cave, D. Niedzwiecki, 2020, Journal of clinical gastroenterology.

Clinical Features and Management of Small Bowel Masses Detected During Device-Assisted Enteroscopy: A Multi-Center Experience

D. Cave, D. Niedzwiecki, Mark Hanscom, 2022, Gastroenterology research.

Acid exposure time is sensitive for detecting gastroesophageal reflux disease and is associated with long-term survival after lung transplant.

D. Fisher, D. Niedzwiecki, D. Leiman, 2022, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

A Phase II Trial of Streptozotocin and Adriamycin in Advanced APUD Tumors

N. Kemeny, D. Niedzwiecki, R. Heelan, 1988, American journal of clinical oncology.

Cost of chemotherapy for metastatic colorectal cancer with either bevacizumab or cetuximab: Economic analysis of CALGB/SWOG 80405.

C. Earle, A. Grothey, A. Venook, 2015 .

Reduced Alcohol Use Is Sustained in Patients Provided Alcohol-Related Counseling During Direct-Acting Antiviral Therapy for Hepatitis C

D. Niedzwiecki, A. Muir, Y. Patel, 2020, Digestive Diseases and Sciences.

A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection

S. Datta, J. Wong, D. Niedzwiecki, 2019, Hepatology.

Classification of older adults who underwent lumbar-related surgery using pre-operative biopsychosocial predictors and relationships with surgical recovery: An observational study conducted in the United States.

C. Simon, D. Niedzwiecki, O. Gottfried, 2021, Health & social care in the community.

Diet- and Lifestyle‐Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance)

D. Spiegelman, C. Gross, J. Meyerhardt, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival rates among patients vaccinated following resection of colorectal cancer metastases in a phase II randomized study compared with contemporary controls.

J. Marshall, T. Crocenzi, D. Niedzwiecki, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer.

N. Kemeny, D. Niedzwiecki, J. Daly, 1987, Gut.

Racial disparities in transjugular intrahepatic portosystemic shunt procedure outcomes

D. Niedzwiecki, A. Muir, A. Parish, 2022, BMJ open gastroenterology.

Immuno-Chemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909.

J. Byrd, B. Cheson, D. Niedzwiecki, 2006 .

Phase I and clinical pharmacology study of trimetrexate administered weekly for three weeks.

T. Chou, M. Fleisher, D. Niedzwiecki, 1987, Cancer research.

Pharmacokinetics of cis-diamminedichloroplatinum(II) after administration in hypertonic saline.

D. Bajorin, G. Bosl, D. Niedzwiecki, 1986, Cancer research.

is merely a description of a new technology, more context would have helped me understand why this is anything other than a cool new gadget looking for investors.

Abraham H. Dachman, Erik K. Paulson, Hayden B. Bosworth, 2006 .

Why do patients with chronic hepatitis C drink alcohol? An examination of pain, depression and drinking motives

D. Niedzwiecki, D. Evon, A. Muir, 2021, Journal of viral hepatitis.

Associations of physical activity with survival and progression in metastatic colorectal cancer: Results from CALGB 80405 (Alliance).

J. Meyerhardt, M. Bertagnolli, C. Fuchs, 2017 .

Low contralateral neck recurrence risk with ipsilateral neck radiotherapy in N2b tonsillar squamous cell carcinoma.

D. Brizel, D. Niedzwiecki, D. Natesan, 2023, Oral Oncology.

Increasing physical activity in Cancer Survivors through a Text-messaging Exercise motivation Program (ICanSTEP)

W. Kraus, D. Niedzwiecki, Lynda Owen, 2021, Supportive Care in Cancer.

Big Data, Small Effects.

D. Niedzwiecki, H. Hochster, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of Diet Quality With Survival Among People With Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 Trial

J. Meyerhardt, E. Giovannucci, C. Atreya, 2020, JAMA network open.

Need for Pretransplant Midodrine Does Not Negatively Impact Simultaneous Liver-kidney Transplant Outcomes

D. Niedzwiecki, Lindsay Y King, L. McElroy, 2020, Transplantation direct.

Blood-based biomarkers in patients (pts) with metastatic colorectal cancer (mCRC) treated with FOLFOX or FOLFIRI plus bevacizumab (Bev), cetuximab (Cetux), or Bev plus Cetux: Results from CALGB 80405 (Alliance).

K. Owzar, H. Lenz, H. Hurwitz, 2016 .

Quality of life (QOL) and toxicity among patients in CALGB 80405.

H. Lenz, A. Venook, D. Schrag, 2013 .

Impact of Race on Outcomes of High-Risk Patients With Prostate Cancer Treated With Moderately Hypofractionated Radiotherapy in an Equal Access Setting.

D. Godfrey, D. Niedzwiecki, W. Lee, 2022, Federal practitioner : for the health care professionals of the VA, DoD, and PHS.

LE-SN38 for metastatic colorectal cancer after progression on oxaliplatin: Results of CALGB 80402

R. Goldberg, D. Niedzwiecki, S. Wadler, 2008 .

Socioeconomic Status, Not Race, Is Associated With Reduced Survival in Esophagectomy Patients.

M. Berry, D. Niedzwiecki, L. Erhunmwunsee, 2017, The Annals of thoracic surgery.

A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study.

J. Marshall, T. Crocenzi, D. Niedzwiecki, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of New Anticancer Agents Against Human Pancreatic Carcinomas in Nude Mice

C. Sternberg, D. Niedzwiecki, P. Sordillo, 1987, American journal of clinical oncology.

Predicting Emergency Visits and Hospital Admissions During Radiation and Chemoradiation: An Internally Validated Pretreatment Machine Learning Algorithm.

Manisha Palta, Julian C. Hong, Donna Niedzwiecki, 2018, JCO clinical cancer informatics.

Impact of age and comorbidities on treatment effect, tolerance, and toxicity in metastatic colorectal cancer (mCRC) patients treated on CALGB 80203.

J. Meyerhardt, R. Goldberg, A. Venook, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of smoking on cancer recurrence and survival in patients with stage III colon cancer: Findings from intergroup trial CALGB 89803

J. Meyerhardt, C. Fuchs, L. Saltz, 2008 .

Image quality and Dose Comparison of Three Mobile Intraoperative 3D imaging Systems in Spine Surgery.

D. Niedzwiecki, C. Shaffrey, R. Turner, 2021, World Neurosurgery.

Establishing ADC-Based Histogram and Texture Features for Early Treatment-Induced Changes in Head and Neck Squamous Cell Carcinoma

O. Craciunescu, D. Brizel, Z. Chang, 2021, Frontiers in Oncology.

Associations Between Unprocessed Red Meat and Processed Meat With Risk of Recurrence and Mortality in Patients With Stage III Colon Cancer

J. Meyerhardt, A. Benson, E. Giovannucci, 2022, JAMA network open.

LBA10CALGB/SWOG 80405: ANALYSIS OF PATIENTS UNDERGOING SURGERY AS PART OF TREATMENT STRATEGY

R. Schilsky, M. Bertagnolli, R. Goldberg, 2014 .

A randomized phase II study of gemcitabine/cisplatin, gemcitabine fixed dose rate infusion, gemcitabine/docetaxel, or gemcitabine/irinotecan in patients with metastatic pancreatic cancer (CALGB 89904).

M. Tempero, D. Hollis, D. Niedzwiecki, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II trial of sunitinib (S) in previously-treated pancreas adenocarcinoma (PAC), CALGB 80603

R. Goldberg, T. Bekaii-Saab, D. Hollis, 2008 .

A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer

K. Blackwell, H. Hurwitz, P. Marcom, 2019, BMC Cancer.

Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803.

J. Meyerhardt, A. Benson, C. Fuchs, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.

J. Meyerhardt, A. Benson, C. Fuchs, 2012, Journal of the National Cancer Institute.

CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.

M. Bertagnolli, M. Emond, R. Goldberg, 2014, Gastroenterology.

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

R. Labianca, J. Meyerhardt, D. Sargent, 2018, The New England journal of medicine.

Gene Expression Markers of Efficacy and Resistance to Cetuximab Treatment in Metastatic Colorectal Cancer: Results from CALGB 80203 (Alliance)

Ivo D. Shterev, K. Owzar, H. Hurwitz, 2014, Clinical Cancer Research.

Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803.

C. Compton, M. Bertagnolli, R. Goldberg, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer.

D. Niedzwiecki, G. Devi, H. Lyerly, 2010, The Journal of clinical investigation.

Adaptive Positron Emission Tomography Radiation Therapy in Patients With Locally Advanced Vulvar Cancer: A Prospective Study

O. Craciunescu, D. Niedzwiecki, J. Chino, 2023, Advances in radiation oncology.

p27Kip1 in Stage III Colon Cancer: Implications for Outcome following Adjuvant Chemotherapy in Cancer and Leukemia Group B Protocol 89803

M. Loda, C. Compton, S. Jewell, 2009, Clinical Cancer Research.

Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581.

D. Kerr, M. Bertagnolli, P. Rougier, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Natural language processing to identify patient symptoms during and prior to cancer therapy

Jessica D. Tenenbaum, Manisha Palta, Julian C. Hong, 2018, AMIA.

Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.

J. Byrd, A. LaCasce, B. Cheson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Predictors of a Positive Ct Angiogram Study Used for the Evaluation of Acute Gastrointestinal Hemorrhage

D. Niedzwiecki, A. Parish, Zachary P. Spiritos, 2022, Digestive Diseases and Sciences.

Estimation and inference in pharmacokinetic models: The effectiveness of model reformulation and resampling methods for functions of parameters

Jeffrey S. Simonoff, Donna Niedzwiecki, J. Simonoff, 1990, Journal of Pharmacokinetics and Biopharmaceutics.

Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance)

W. Willett, J. Meyerhardt, A. Benson, 2018, PloS one.

Reply to L. Casadaban et al.

R. Schilsky, M. Bertagnolli, T. Davison, 2017, Journal of Clinical Oncology.

Outcomes for FOLFIRI plus bevacizumab (BEV) or cetuximab (CET) in patients previously treated with oxaliplatin-based adjuvant therapy: A combined analysis of data from FIRE-3 and CALGB 80405.

R. Schilsky, M. Bertagnolli, R. Goldberg, 2015 .

A phase II, open label study of tucatinib (ONT-380) combined with trastuzumab in patients with HER2+ metastatic colorectal cancer (mCRC)(MOUNTAINEER).

A. Grothey, A. Cercek, M. Fakih, 2017 .